Rethinking nonadherence: historical perspectives on triple-drug therapy for HIV disease.
about
Critical reflections on evidence, ethics and effectiveness in the management of tuberculosis: public health and global perspectivesProblem drinking and medication adherence among persons with HIV infectionAdherence to antimicrobial inhalational anthrax prophylaxis among postal workers, Washington, D.C., 2001Patients' perspectives on informal caregiver involvement in HIV health care appointments.Specialty care use in US patients with chronic diseases.Factors affecting adherence to antiretroviral therapy.Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS.Dealing with AIDS-related loss and grief in a time of treatment advances.Strategies for optimizing adherence to highly active antiretroviral therapy: lessons from research and clinical practice.Disparities in HIV treatment and physician attitudes about delaying protease inhibitors for nonadherent patientsBetter physician-patient relationships are associated with higher reported adherence to antiretroviral therapy in patients with HIV infectionHIV-seropositive individuals' optimistic beliefs about prognosis and relation to medication and safe sex adherence.Taking antiretroviral therapy for HIV infection: learning from patients' stories.Is it justifiable to withhold treatment for hepatitis C from illicit-drug users?Medical illness and comorbidities in drug users: implications for addiction pharmacotherapy treatment.What's in a name? Medication terms: what they mean and when to use them.Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoringBeyond decision making: class, community organizations, and the healthwork of people living with HIV/AIDS. Contributions from institutional ethnographic research.Self-reported symptoms after initiation of a protease inhibitor in HIV-infected patients and their impact on adherence to HAART.Individualized stepped care of chronic illness.British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy.Adherence to antiretroviral therapy among HIV-infected methadone patients: effect of ongoing illicit drug use.Failure to maintain adherence to HAART in a cohort of French HIV-positive injecting drug users.Placebo practice trials: the best predictor of adherence readiness for HAART among drug users?Placebo practice trials: a tool to assess and improve adherence readiness.Quality Care for People with HIV/AIDS: patients' perspectives.Time, self and the medication day: a closer look at the everyday work of 'adherence'.British HIV Association (BHIVA)/British Association for Sexual Health and HIV (BASHH) guidelines on provision of adherence support to individuals receiving antiretroviral therapy (2003).Adherence to antiretroviral therapy: appropriate use of self-reporting in clinical practice.Physicians' attitudes and practices regarding adherence to medical regimens by patients with chronic illness.Medication practice and feminist thought: a theoretical and ethical response to adherence in HIV/AIDS.From directly observed therapy to accompagnateurs: enhancing AIDS treatment outcomes in Haiti and in Boston.Editorial: HIV/AIDS: a long-term research agenda for social sciencesNonadherence to HIV Treatment: Implications for Health Educators
P2860
Q24806309-759CBF52-13EE-42B2-8780-456557F4D617Q28360406-B80BD409-DAEA-413F-9C46-30AD55CD3F9BQ28390552-DCE73BAD-E3E2-4BC8-B8FA-F428132C0265Q33705650-6F2C9F52-815A-4CA3-A8C9-B146171F3B9DQ33858822-3EA9BCBF-AD8F-422B-AE9E-4153380768F7Q33946925-6718E072-D379-49F6-9416-25C995D92B6CQ33978365-7AC736EC-04C9-45F9-8841-C8C0AF1A0E48Q34282955-62C2FBD9-CDB3-4BC1-A87A-5847E3134667Q34340996-FA1D96A3-FA36-4E37-B9C8-71A97E742B00Q34732022-E30B6166-D424-41A2-B18C-6BAC090C1B63Q34740754-4632637A-47D8-41FE-A572-2098BB35DD62Q34743360-0F6D8DE1-174F-4275-99FF-2F58998A6EA7Q34746954-5719ACC1-0517-4AF2-B0C1-868ECEAC939EQ34795087-CBB67399-631E-4462-9C2E-8BAAF6AE3535Q36311018-1B2F1C0E-FED6-4CBF-9635-46ED31544AF7Q36975527-BCB094E5-99BB-4E52-BB06-AD410A3DC9FBQ37217490-6DDBAE45-3C54-4E13-AB36-D227D8D6D4BAQ39845651-B2E402BC-D66A-45CF-94DF-EBE591A13AD4Q40682598-D6E0E53A-5F92-4A20-98CD-20AE74FF5C83Q42711164-2124F351-502B-4339-A053-693211F021FDQ43818117-85B7E4E6-83A5-425A-AF06-703B3A73AE69Q43890758-1ACE3530-2E79-4DC0-A108-445296C27693Q44110290-3B55CA49-20D9-4037-B2C5-BB92B0D67F55Q44233666-4B938057-F6F8-4FB8-84DE-B662EFC153B2Q46168619-0CF009E7-C584-4446-9403-C2DE36B3E294Q46450520-F42FA741-DD01-4DD9-A824-E2464D4DEB6AQ47622906-FB9A4F09-B27F-425A-856F-5838EC1BDEE2Q50145443-A92CCE45-DADB-4ED7-B5C9-192C0B09573CQ51963053-6FB2FCDD-3625-46C5-94CF-252360C36CB9Q52010701-8F08B2D5-1C83-406C-AF98-B8A62CAE8EC7Q53275051-A98A2E00-1E2A-4A43-AD90-A80AAC17DDC8Q53894813-8A78EBFA-BC85-451A-B194-B31AE8EC40A9Q58181375-33D79B34-3BE5-4407-89CD-C6E6FA649AB2Q58283543-A5F3F311-9F69-4276-9F32-CAC0FD6D3150
P2860
Rethinking nonadherence: historical perspectives on triple-drug therapy for HIV disease.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Rethinking nonadherence: historical perspectives on triple-drug therapy for HIV disease.
@en
Rethinking nonadherence: historical perspectives on triple-drug therapy for HIV disease.
@nl
type
label
Rethinking nonadherence: historical perspectives on triple-drug therapy for HIV disease.
@en
Rethinking nonadherence: historical perspectives on triple-drug therapy for HIV disease.
@nl
prefLabel
Rethinking nonadherence: historical perspectives on triple-drug therapy for HIV disease.
@en
Rethinking nonadherence: historical perspectives on triple-drug therapy for HIV disease.
@nl
P2093
P1476
Rethinking nonadherence: historical perspectives on triple-drug therapy for HIV disease.
@en
P2093
P304
P356
10.7326/0003-4819-129-7-199810010-00012
P407
P577
1998-10-01T00:00:00Z